{"id":1503,"date":"2018-10-23T09:25:05","date_gmt":"2018-10-23T07:25:05","guid":{"rendered":"http:\/\/www.nanexa.com\/?p=1503"},"modified":"2018-10-23T09:25:05","modified_gmt":"2018-10-23T07:25:05","slug":"nanexa-presenterade-pharmashell-pa-partnership-opportunities-in-drug-development-podd-i-boston","status":"publish","type":"post","link":"https:\/\/nanexa.com\/sv\/nanexa-presenterade-pharmashell-pa-partnership-opportunities-in-drug-development-podd-i-boston\/","title":{"rendered":"Nanexa presenterade PharmaShell\u00ae p\u00e5 Partnership Opportunities in Drug Development (PODD) i Boston"},"content":{"rendered":"<p><strong>Nyhetsbrev <\/strong><\/p>\n<p>Uppsala 2018-10-22<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Nanexa presenterade PharmaShell<sup>\u00ae\u00a0<\/sup>p\u00e5 Partnership Opportunities in Drug Development (PODD) i Boston. <\/strong><\/p>\n<p>Nanexa deltog som technology sponsor p\u00e5 konferensen PODD i Boston under f\u00f6rra veckan. En konferens som fokuserar p\u00e5 drug delivery och med deltagare fr\u00e5n m\u00e5nga av de stora globala l\u00e4kemedelsf\u00f6retagen.<\/p>\n<p>Som sponsor hade vi m\u00f6jligheten att f\u00f6r en bred publik presentera v\u00e5r drug delivery-plattform PharmaShell<sup>\u00ae<\/sup>. Att delta aktivt i konferensprogrammet \u00e4r helt i linje med att etablera Nanexa som ett framst\u00e5ende och nyt\u00e4nkande drug delivery-f\u00f6retag.<\/p>\n<p>Flertalet presentat\u00f6rer fr\u00e5n de stora internationella l\u00e4kemedelsbolagen fokuserade sitt budskap bl.a. p\u00e5 vikten av att kunna utveckla l\u00e4kemedel f\u00f6r subkutan administrering och l\u00e5nga dep\u00e5tider, en trend som vi redan tidigare f\u00e5ngat upp och d\u00e4r PharmaShell<sup>\u00ae<\/sup>med dess m\u00f6jlighet att skapa l\u00e5nga dep\u00e5er passar in v\u00e4l.<\/p>\n<p><strong>\u00a0<\/strong><strong>\u00a0<\/strong><\/p>\n<p>F\u00f6r mer information kontakta:<br \/>\nDavid Westberg \u2013 VD, Nanexa AB (publ)<br \/>\nTelefon: 0709 &#8211; 42 83 03<br \/>\nE-post:\u00a0<a href=\"mailto:david.westberg@nanexa.se\">david.westberg@nanexa.se<\/a><br \/>\nwww.nanexa.com<\/p>\n<p>&nbsp;<\/p>\n<p>Om Nanexa AB (publ)<\/p>\n<p>Nanexa AB \u00e4r ett nanoteknologiskt drug delivery-f\u00f6retag som fokuserar verksamheten p\u00e5 utvecklingen av PharmaShell<sup>\u00ae<\/sup>som \u00e4r ett nytt och banbrytande drug delivery-system som bed\u00f6ms ha en stor potential inom ett flertal indikationsomr\u00e5den. Inom ramen f\u00f6r PharmaShell<sup>\u00ae<\/sup>har Nanexa samarbetsavtal med bland andra AstraZeneca.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nyhetsbrev <\/p>\n<p>Uppsala 2018-10-22<\/p>\n<p>&nbsp;<\/p>\n<p>Nanexa presenterade PharmaShell\u00ae\u00a0p\u00e5 Partnership Opportunities in Drug Development (PODD) i Boston. <\/p>\n<p>Nanexa deltog som technology sponsor p\u00e5 konferensen PODD i Boston under f\u00f6rra veckan.<\/p>\n<p><a class=\"read-more\" href=\"https:\/\/nanexa.com\/sv\/nanexa-presenterade-pharmashell-pa-partnership-opportunities-in-drug-development-podd-i-boston\/\">L\u00e4s mer<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[7],"tags":[],"class_list":["post-1503","post","type-post","status-publish","format-standard","hentry","category-nyheter"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nanexa presenterade PharmaShell\u00ae p\u00e5 Partnership Opportunities in Drug Development (PODD) i Boston - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/nanexa-presenterade-pharmashell-pa-partnership-opportunities-in-drug-development-podd-i-boston\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanexa presenterade PharmaShell\u00ae p\u00e5 Partnership Opportunities in Drug Development (PODD) i Boston - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"Nyhetsbrev Uppsala 2018-10-22 &nbsp; Nanexa presenterade PharmaShell\u00ae\u00a0p\u00e5 Partnership Opportunities in Drug Development (PODD) i Boston. Nanexa deltog som technology sponsor p\u00e5 konferensen PODD i Boston under f\u00f6rra veckan.L\u00e4s mer\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/nanexa-presenterade-pharmashell-pa-partnership-opportunities-in-drug-development-podd-i-boston\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta property=\"article:published_time\" content=\"2018-10-23T07:25:05+00:00\" \/>\n<meta name=\"author\" content=\"Anders Johansson\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Skriven av\" \/>\n\t<meta name=\"twitter:data1\" content=\"Anders Johansson\" \/>\n\t<meta name=\"twitter:label2\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-presenterade-pharmashell-pa-partnership-opportunities-in-drug-development-podd-i-boston\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-presenterade-pharmashell-pa-partnership-opportunities-in-drug-development-podd-i-boston\\\/\"},\"author\":{\"name\":\"Anders Johansson\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/person\\\/d26735c022a71d41737953c23a07692a\"},\"headline\":\"Nanexa presenterade PharmaShell\u00ae p\u00e5 Partnership Opportunities in Drug Development (PODD) i Boston\",\"datePublished\":\"2018-10-23T07:25:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-presenterade-pharmashell-pa-partnership-opportunities-in-drug-development-podd-i-boston\\\/\"},\"wordCount\":237,\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"articleSection\":[\"Nyheter\"],\"inLanguage\":\"sv-SE\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-presenterade-pharmashell-pa-partnership-opportunities-in-drug-development-podd-i-boston\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/nanexa-presenterade-pharmashell-pa-partnership-opportunities-in-drug-development-podd-i-boston\\\/\",\"name\":\"Nanexa presenterade PharmaShell\u00ae p\u00e5 Partnership Opportunities in Drug Development (PODD) i Boston - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2018-10-23T07:25:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-presenterade-pharmashell-pa-partnership-opportunities-in-drug-development-podd-i-boston\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/nanexa-presenterade-pharmashell-pa-partnership-opportunities-in-drug-development-podd-i-boston\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-presenterade-pharmashell-pa-partnership-opportunities-in-drug-development-podd-i-boston\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanexa presenterade PharmaShell\u00ae p\u00e5 Partnership Opportunities in Drug Development (PODD) i Boston\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/person\\\/d26735c022a71d41737953c23a07692a\",\"name\":\"Anders Johansson\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g\",\"caption\":\"Anders Johansson\"},\"url\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/author\\\/anders\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nanexa presenterade PharmaShell\u00ae p\u00e5 Partnership Opportunities in Drug Development (PODD) i Boston - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/nanexa-presenterade-pharmashell-pa-partnership-opportunities-in-drug-development-podd-i-boston\/","og_locale":"sv_SE","og_type":"article","og_title":"Nanexa presenterade PharmaShell\u00ae p\u00e5 Partnership Opportunities in Drug Development (PODD) i Boston - Nanexa AB","og_description":"Nyhetsbrev Uppsala 2018-10-22 &nbsp; Nanexa presenterade PharmaShell\u00ae\u00a0p\u00e5 Partnership Opportunities in Drug Development (PODD) i Boston. Nanexa deltog som technology sponsor p\u00e5 konferensen PODD i Boston under f\u00f6rra veckan.L\u00e4s mer","og_url":"https:\/\/nanexa.com\/nanexa-presenterade-pharmashell-pa-partnership-opportunities-in-drug-development-podd-i-boston\/","og_site_name":"Nanexa AB","article_published_time":"2018-10-23T07:25:05+00:00","author":"Anders Johansson","twitter_card":"summary_large_image","twitter_misc":{"Skriven av":"Anders Johansson","Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanexa.com\/nanexa-presenterade-pharmashell-pa-partnership-opportunities-in-drug-development-podd-i-boston\/#article","isPartOf":{"@id":"https:\/\/nanexa.com\/nanexa-presenterade-pharmashell-pa-partnership-opportunities-in-drug-development-podd-i-boston\/"},"author":{"name":"Anders Johansson","@id":"https:\/\/nanexa.com\/#\/schema\/person\/d26735c022a71d41737953c23a07692a"},"headline":"Nanexa presenterade PharmaShell\u00ae p\u00e5 Partnership Opportunities in Drug Development (PODD) i Boston","datePublished":"2018-10-23T07:25:05+00:00","mainEntityOfPage":{"@id":"https:\/\/nanexa.com\/nanexa-presenterade-pharmashell-pa-partnership-opportunities-in-drug-development-podd-i-boston\/"},"wordCount":237,"publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"articleSection":["Nyheter"],"inLanguage":"sv-SE"},{"@type":"WebPage","@id":"https:\/\/nanexa.com\/nanexa-presenterade-pharmashell-pa-partnership-opportunities-in-drug-development-podd-i-boston\/","url":"https:\/\/nanexa.com\/nanexa-presenterade-pharmashell-pa-partnership-opportunities-in-drug-development-podd-i-boston\/","name":"Nanexa presenterade PharmaShell\u00ae p\u00e5 Partnership Opportunities in Drug Development (PODD) i Boston - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2018-10-23T07:25:05+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/nanexa-presenterade-pharmashell-pa-partnership-opportunities-in-drug-development-podd-i-boston\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/nanexa-presenterade-pharmashell-pa-partnership-opportunities-in-drug-development-podd-i-boston\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/nanexa-presenterade-pharmashell-pa-partnership-opportunities-in-drug-development-podd-i-boston\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"Nanexa presenterade PharmaShell\u00ae p\u00e5 Partnership Opportunities in Drug Development (PODD) i Boston"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nanexa.com\/#\/schema\/person\/d26735c022a71d41737953c23a07692a","name":"Anders Johansson","image":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/secure.gravatar.com\/avatar\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g","caption":"Anders Johansson"},"url":"https:\/\/nanexa.com\/sv\/author\/anders\/"}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts\/1503","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/comments?post=1503"}],"version-history":[{"count":3,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts\/1503\/revisions"}],"predecessor-version":[{"id":1506,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts\/1503\/revisions\/1506"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=1503"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/categories?post=1503"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/tags?post=1503"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}